Walleye Capital’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-95,100
Closed -$952K 800
2020
Q2
$952K Buy
+95,100
New +$952K 0.21% 138